| RS2062339211 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2062351829 |
FAN1
|
Health Risk |
Likely pathogenic |
Karyomegalic interstitial nephritis, Karyomegalic interstitial nephritis |
| RS2062365477 |
ADA2
|
Health Risk |
Likely pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2062392148 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2062393838 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2062397306 |
ADA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2062410421 |
WAS
|
Health Risk |
Pathogenic |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS2062410722 |
WAS
|
Health Risk |
Pathogenic |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS2062412197 |
WAS
|
Health Risk |
Likely pathogenic |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS2062412365 |
WAS
|
Health Risk |
Pathogenic |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS2062412730 |
WAS
|
Health Risk |
Pathogenic |
Thrombocytopenia 1, Wiskott-Aldrich syndrome |
| RS2062412810 |
WAS
|
Health Risk |
Pathogenic |
Wiskott-Aldrich syndrome, X-linked severe congenital neutropenia |
| RS2062416187 |
WAS
|
Health Risk |
Pathogenic |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS2062416272 |
WAS
|
Health Risk |
Pathogenic |
Wiskott-Aldrich syndrome, X-linked severe congenital neutropenia |
| RS2062416328 |
WAS
|
Health Risk |
Pathogenic |
— |
| RS2062417344 |
WAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Wiskott-Aldrich syndrome, Wiskott-Aldrich syndrome |
| RS2062417558 |
WAS
|
Health Risk |
Pathogenic |
Thrombocytopenia 1, Wiskott-Aldrich syndrome |
| RS2062418811 |
WAS
|
Health Risk |
Likely pathogenic |
Wiskott-Aldrich syndrome, Wiskott-Aldrich syndrome |
| RS2062419468 |
USP9X
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2062422078 |
WAS
|
Health Risk |
Pathogenic |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS2062426981 |
WAS
|
Health Risk |
Likely pathogenic |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS2062429013 |
WAS
|
Health Risk |
Pathogenic |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS2062432605 |
WAS
|
Health Risk |
Pathogenic |
Wiskott-Aldrich syndrome, Wiskott-Aldrich syndrome |
| RS2062432653 |
WAS
|
Health Risk |
Pathogenic |
Wiskott-Aldrich syndrome, Wiskott-Aldrich syndrome |
| RS2062434410 |
CTNND1
|
Health Risk |
Likely pathogenic |
Blepharocheilodontic syndrome 2, Blepharocheilodontic syndrome 2 |
| RS2062455934 |
GDF5
|
Health Risk |
Pathogenic |
— |
| RS2062463484 |
GDF5
|
Health Risk |
Pathogenic |
— |
| RS2062480958 |
GDF5
|
Health Risk |
Pathogenic |
— |
| RS2062564269 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS2062565976 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2062566338 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiac arrhythmia |
| RS2062566545 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2062567690 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2062606991 |
ACBD5
|
Health Risk |
Likely pathogenic |
Retinal dystrophy with leukodystrophy, Retinal dystrophy with leukodystrophy |
| RS2062611307 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2062620327 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2062621871 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2062662018 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2062673272 |
GATA1
|
Health Risk |
Pathogenic |
Transient myeloproliferative syndrome, Transient myeloproliferative syndrome |
| RS2062673416 |
GATA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2062673523 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2062673530 |
GATA1
|
Health Risk |
Pathogenic |
Transient myeloproliferative syndrome, Transient myeloproliferative syndrome |
| RS2062673787 |
GATA1
|
Health Risk |
Pathogenic |
GATA binding protein 1 related thrombocytopenia with dyserythropoiesis, Diamond-Blackfan anemia |
| RS2062673859 |
GATA1
|
Health Risk |
Pathogenic |
Acute megakaryoblastic leukemia in down syndrome, Acute megakaryoblastic leukemia in down syndrome |
| RS2062673949 |
GATA1
|
Health Risk |
Pathogenic |
Acute megakaryoblastic leukemia in down syndrome, Acute megakaryoblastic leukemia in down syndrome |
| RS2062674043 |
GATA1
|
Health Risk |
Pathogenic |
Transient myeloproliferative syndrome, Transient myeloproliferative syndrome |
| RS2062674122 |
GATA1
|
Health Risk |
Pathogenic |
Acute megakaryoblastic leukemia in down syndrome, Acute megakaryoblastic leukemia in down syndrome |
| RS2062674253 |
GATA1
|
Health Risk |
Pathogenic |
Acute megakaryoblastic leukemia in down syndrome, Acute megakaryoblastic leukemia in down syndrome |
| RS2062674480 |
GATA1
|
Health Risk |
Pathogenic |
Acute megakaryoblastic leukemia in down syndrome, Acute megakaryoblastic leukemia in down syndrome |
| RS2062674491 |
GATA1
|
Health Risk |
Pathogenic |
Transient myeloproliferative syndrome, Transient myeloproliferative syndrome |
| RS2062675453 |
USP9X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 99 |
| RS2062676091 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS2062693263 |
FITM2
|
Health Risk |
Likely pathogenic |
— |
| RS2062763812 |
ATRX
|
Health Risk |
Pathogenic |
— |
| RS2062777274 |
NRCAM
|
Health Risk |
Pathogenic |
NRCAM-related disorder, Neurodevelopmental disorder with neuromuscular and skeletal abnormalities |
| RS2062783271 |
PTHLH
|
Health Risk |
Pathogenic |
— |
| RS2062862935 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2062912705 |
PDHB
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-beta deficiency, Pyruvate dehydrogenase E1-beta deficiency |
| RS2062921303 |
PDHB
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-beta deficiency, Pyruvate dehydrogenase E1-beta deficiency |
| RS2062941991 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2062944024 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2062949363 |
CTNND1
|
Health Risk |
Likely pathogenic |
Cleft lip with or without cleft palate, Cleft lip with or without cleft palate |
| RS2062964886 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Tibial muscular dystrophy, Early-onset myopathy with fatal cardiomyopathy |
| RS2062986710 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS2062994512 |
USP9X
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2063008265 |
MOV10L1
|
Health Risk |
Likely pathogenic |
Male infertility, Male infertility |
| RS2063018968 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2063052002 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS2063072465 |
CTNND1
|
Health Risk |
Pathogenic |
Cleft lip with or without cleft palate, Cleft lip with or without cleft palate |
| RS2063076388 |
NEFH
|
Health Risk |
Pathogenic |
— |
| RS2063076425 |
NEFH
|
Health Risk |
Likely pathogenic |
— |
| RS2063099465 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2063100815 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS2063102803 |
MAX
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2063103516 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2063103741 |
COL4A4
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS2063104349 |
MAX
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2063104408 |
MAX
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2063106020 |
MAX
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, MAX-associated Macrocephaly and Polydactyly syndrome |
| RS2063135938 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2063155917 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2063162114 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Thyroid cancer |
| RS2063174067 |
PDHA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Neurodevelopmental delay |
| RS2063188850 |
PDHA1
|
Health Risk |
Likely pathogenic |
— |
| RS2063189233 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2063189611 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2063192428 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2063192913 |
PDHA1
|
Health Risk |
Pathogenic |
— |
| RS2063210388 |
USP9X
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2063213272 |
PDHA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2063213305 |
USP9X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 99 |
| RS2063213396 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2063213491 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Nonpapillary renal cell carcinoma |
| RS2063220564 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS2063220897 |
GSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish type amyloidosis, Finnish type amyloidosis |
| RS2063221553 |
USP9X
|
Health Risk |
Likely pathogenic |
— |
| RS2063232292 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2063232730 |
PDHA1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2063232824 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2063233462 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |